Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Quantum Biopharma's subsidiary, Huge Biopharma Australia, has cleared a regulatory milestone for its neuroprotective compou...
https://www.marijuanamoment.net/texas-governor-signs-bill-to-create-ibogaine-research-consortium-aiming-to-develop-fda-approved...
https://www.marijuanamoment.net/colorado-governor-says-bill-he-signed-allowing-psychedelic-convictions-to-be-pardoned-marks-a-s...
https://www.marijuanamoment.net/doctor-seeking-to-res
Last week had Wall Street facing volatility, tech earnings disappointments, mixed labor data, and rising inflation fears. Gold ...
Clearmind Medicine's stock rose 63.9% after receiving IRB approval for its Phase I/IIa trial of CMND-100, a drug for alcoho...
AdvisorShares, a leading sponsor of actively managed exchange-traded funds (ETFs), has announced a reverse split of the issued ...
FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit,...
